RIV investee to finish CBD facility in fall

Seite 1 von 1
Neuester Beitrag: 25.02.21 21:59
Eröffnet am: 12.02.19 15:39 von: Medical Anzahl Beiträge: 7
Neuester Beitrag: 25.02.21 21:59 von: Medical Leser gesamt: 2.282
Forum: Hot-Stocks   Leser heute: 1
Bewertet mit:


487 Postings, 1274 Tage MedicalRIV investee to finish CBD facility in fall

12.02.19 15:39
Zitat:"Canopy Rivers Inc. has provided an update on the operations of Canapar SrL, an Italian-based hemp production and processing platform  ....hosted a ribbon cutting ceremony for its new cannabidiol (CBD) extraction and processing facility. When completed in fall 2019, this facility is expected to be the largest in Europe. Through its advanced extraction and processing capabilities, it is anticipated to transform 600 metric tons of hemp biomass annually into CBD isolates and derivative products for distribution in the European market.... "In a short time, Canapar has achieved several significant milestones, positioning the company as a leader in the nascent European CBD vertical. With over 1,000 hectares of hemp secured, strong partnerships with Italian universities and this new facility, Canapar is well positioned to supply Europe's demand for CBD-derived products. The company is on the path to bring to market products ranging from CBD isolates to made-in-Italy beauty products to pharmaceutical products," said Olivier Dufourmantelle, chief operating officer of Canopy Rivers....
Management believes Canapar is playing an important role in developing and commercializing the CBD and hemp industry in Italy and Europe. Canapar is seeking to optimize the cultivation and extraction processes of the active ingredients derived from hemp that are used in consumer products, particularly for the cosmetic, natural health and pharmaceutical markets... "ENDE Zitat

487 Postings, 1274 Tage MedicalRIV closes $1.5M investment in Herbert

12.02.19 15:41
Zitat:"Canopy Rivers Inc. has completed an equity investment in 10663522 Canada Inc., or Herbert, a unique brand platform that focuses on the adult-use cannabis beverage and edibles market. Canopy Rivers subscribed for $1.5-million of preferred shares in Herbert, and received incremental warrants entitling the company to increase its economic interest in Herbert under certain circumstances, as well as other governance-related rights...."Herbert represents an opportunity for Canopy Rivers to be invested at a very early stage in a company focused on the adult-use cannabis beverage and edible product segment," said Narbe Alexandrian, president of Canopy Rivers. "In the U.S., cannabis-infused beverages have emerged as a high-growth segment within the ingestibles category, and include a variety of products in both THC- and CBD-dominant formats. In Canada, we expect similar growth beyond dried flower and oils, into food and beverage. Canopy Rivers believes that Herbert, equipped with existing R&D, marketing and manufacturing expertise, has the ability to enter this market quickly and achieve success in creating widely appealing THC-infused beverages and edibles under this new stand-alone brand."..."We are thrilled to be partnering with Canopy Rivers, one of the most progressive players in the global cannabis sector," said Lee Reitelman, co-founder and director of marketing at Herbert. " ENDE Zitat

487 Postings, 1274 Tage MedicalRIV invests another $9.4-million in Canapar Corp.

12.02.19 15:44
Zitat:" Canopy Rivers Inc. has completed a subsequent $9.4-million equity investment in its portfolio company Canapar Corp., the Canadian parent corporation of Canapar SrL (Canapar Italy), an Italy-based organic hemp production and processing platform. The investment aligns with the company's global-focused growth strategy and is expected to provide the company with the opportunity to capitalize on the rapidly expanding European cannabidiol (CBD) market....In December, 2018, the company committed to an investment of $17.4-million in Canapar Canada as part of a $25-million non-brokered private placement. The investments in Canapar Canada have increased the company's ownership position from 35 per cent to 49 per cent on a non-diluted basis. As previously disclosed, Canapar Italy is a Sicily-based manufacturer and processor of CBD oil and isolates, which are increasingly used as an input into new commercial products in the health and wellness industries. Canapar Italy has secured more than 1,000 hectares of hemp through its outsource farming model...... " ENDE

487 Postings, 1274 Tage MedicalCGC increase it total investment in RIV by $30Mil.

12.02.19 15:49
Zitat:"Canopy Growth Corp. intends to increase its total investment in Canopy Rivers Inc. by $30-million. The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers concurrent with Canopy Rivers bought-deal offering of subordinate voting shares for gross proceeds of approximately $55-million. This investment is being co-led by CIBC Capital Markets and Eight Capital and is expected to close on or about Feb. 27, 2019......After the closing of the bought-deal and concurrent private placement, Canopy Growth will increase its ownership of Canopy Rivers' issued and outstanding shares, including both the subordinate voting shares and the multiple voting shares in the capital of Canopy Rivers that are only held by Canopy Growth, on a non-diluted basis from approximately 26.5 per cent to approximately 27.3 per cent.... ENDE Zitat

487 Postings, 1274 Tage MedicalRIV released financial results

07.03.19 07:58
Zitat:" Feb. 27, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (CNPOF) (the “Company” or “Canopy Rivers”) (TSXV: RIV) todays for the three and nine months ended December 31, 2018. The Company’s full Management's Discussion and Analysis (the “MD&A”) and unaudited condensed interim consolidated financial statements for the three and nine months ended December 31, 2018 are available on the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at www.canopyrivers.com/financials..." -ENDE Zitat

487 Postings, 1274 Tage Medicalfirst & only cannabis op. with sales in US,CA,EU

03.05.19 14:27
Zitat:"Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER) (OTCQX: TRSSF) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). TerrAscend also entered into a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH ("iuvo"), a German pharmaceutical wholesaler. ....Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization. Through iuvo, management at TerrAscend expects to begin shipping pharmaceutical-grade cannabis products into Germany................."We applaud TerrAscend for achieving one of the highest and most rigorous levels of quality certification in the world," said Narbe Alexandrian, President of Canopy Rivers. "TerrAscend is now one of select Canadian licensed producers that have been issued EU GMP certificates, and with its new distribution arrangement with iuvo, becomes the ".. " ENDE Zitat


487 Postings, 1274 Tage MedicalCanopy Rivers Corp. changed into RIV Capital

25.02.21 21:59
Zitat:"...Pursuant to the Arrangement, RIV Capital, through its wholly-owned subsidiary, RIV Capital Corporation (formerly Canopy Rivers Corporation) ("RCC"), transferred its interests in TerrAscend Corp. ("TerrAscend"), TerrAscend Canada Inc. ("TerrAscend Canada"), Les Serres Vert Cannabis Inc. ("Vert Mirabel") (other than the shares transferred to Serres Bertrand as described below), and The Tweed Tree Lot Inc. ("Tweed Tree Lot") (collectively, the "Transferred Assets") to Canopy Growth in exchange for approximately $115 million in cash, 3,647,902 common shares of Canopy Growth (having a value of approximately $170.3 million as at the close of trading on the Toronto Stock Exchange (the "TSX") on February 22, 2021), and the cancellation of all 36,468,318 Multiple Voting Shares ("MVS") and 15,223,938 Subordinate Voting Shares ("SVS") of RIV Capital held by Canopy Growth. .." ENDE Zitat

Zitat II. : "..The Toronto Stock Exchange reports that Canopy Rivers Inc. has changed its name to RIV Capital Inc., effective at the open on Feb. 25, 2021. According to the TSX, the company's Class A subordinate voting shares have also been reclassified into Class A common shares, pursuant to a recently completed plan of arrangement involving the company, its wholly owned subsidiary, Canopy Rivers Corp., and Canopy Growth Corp., among others. The company will continue trading under the symbol RIV. The new Cusip number is 768014 10 2. .... " ENDE Zitat II.

   Antwort einfügen - nach oben